Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with ...

Dr. Babajide Ogunseinde, a orthopedic spine surgeon with Longview Orthopedics Regional Clinics, designed a unique technique to treat sacroiliac joint dysfunction.

Victor Buzon, APRN; LaMisa Rayside; APRN; Genesis Lopez, APRN; Dayna Vecchione-Curley, APRN; Grace Choe, APRN; Daniel Prieto ...

PainTEQ has received a new US patent for its LinQ SI Joint Stabilization System aimed at alleviating sacroiliac (SI) joint ...

PainTEQ, a leader in minimally invasive sacroiliac (SI) joint dysfunction treatment, has been awarded a new patent (US Patent ...

The aim of this work was to evaluate the efficacy and safety of sacral neuromodulation (SNM) in the treatment of neurogenic bladder (NB) and neurogenic bowel dysfunction (NBD). A systematic literature ...

A man has been awarded $412m (£325m) in damages after a US clinic gave him "invasive erectile dysfunction shots" that caused him irreversible harm. Jurors in New Mexico awarded the man the record ...